Before treatment initiation , telaprevir-resistant variants ( T54A , T54S , or R155K in 1 % -2 % of the viral population ) were detected by DS in a fraction ( 2 % ) of patients for whom PS failed to detect resistance ; these variants were not necessarily detected at the time of treatment failure .